Lin HM - Search Results

1

Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors.

Lin HM, Pan X, Hou P, Huang H, Wu Y, Ren K, Jahanzeb M. Lin HM, et al. J Med Econ. 2020 Aug;23(8):894-901. doi: 10.1080/13696998.2020.1762620. Epub 2020 May 21. J Med Econ. 2020. PMID: 32347754 Free article.

2

Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.

Burudpakdee C, Lin HM, Wang W, Seetasith A, Zhu Y, Bonthapally V, Carson KR. Burudpakdee C, et al. Among authors: lin hm. J Med Econ. 2016 Oct;19(10):965-72. doi: 10.1080/13696998.2016.1187622. Epub 2016 May 26. J Med Econ. 2016. PMID: 27152635 Free article.

3

Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myeloma.

Hari P, Lin HM, Zhu Y, Berg D, Richardson PG, Moreau P. Hari P, et al. Among authors: lin hm. J Med Econ. 2018 Aug;21(8):793-798. doi: 10.1080/13696998.2018.1474745. Epub 2018 May 29. J Med Econ. 2018. PMID: 29741409 Free article. Clinical Trial.

4

Comparative efficacy of brigatinib versus ceritinib and alectinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small cell lung cancer.

Reckamp K, Lin HM, Huang J, Proskorovsky I, Reichmann W, Krotneva S, Kerstein D, Huang H, Lee J. Reckamp K, et al. Among authors: lin hm. Curr Med Res Opin. 2019 Apr;35(4):569-576. doi: 10.1080/03007995.2018.1520696. Epub 2018 Oct 5. Curr Med Res Opin. 2019. PMID: 30286627

5

Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study.

Kawata AK, Lenderking WR, Eseyin OR, Kerstein D, Huang J, Huang H, Zhang P, Lin HM. Kawata AK, et al. Among authors: lin hm. J Med Econ. 2019 Sep;22(9):924-935. doi: 10.1080/13696998.2019.1624080. Epub 2019 Jun 25. J Med Econ. 2019. PMID: 31125274 Free article. Clinical Trial.

6

Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA).

Lenderking WR, Lin H, Speck RM, Zhu Y, Huang H, Huang J, Kerstein D, Langer CJ. Lenderking WR, et al. Future Oncol. 2019 Aug;15(24):2841-2855. doi: 10.2217/fon-2019-0185. Epub 2019 Jul 31. Future Oncol. 2019. PMID: 31364872 Clinical Trial.

7

Real-world treatment duration in ALK-positive non-small-cell lung cancer patients receiving brigatinib through the early access program.

Lin HM, Pan X, Hou P, Allen S, Baumann P, Hochmair MJ. Lin HM, et al. Future Oncol. 2020 May;16(15):1031-1041. doi: 10.2217/fon-2019-0849. Epub 2020 Apr 27. Future Oncol. 2020. PMID: 32338548 Free article.

8

Real-World Treatment Patterns and Progression-Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non-Small Cell Lung Cancer.

Jahanzeb M, Lin HM, Pan X, Yin Y, Wu Y, Nordstrom B, Socinski MA. Jahanzeb M, et al. Among authors: lin hm. Oncologist. 2020 Oct;25(10):867-877. doi: 10.1634/theoncologist.2020-0011. Epub 2020 Jul 23. Oncologist. 2020. PMID: 32490560 Free PMC article.

9

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.

Camidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, Lee KH, Delmonte A, García Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira A, Gettinger SN, Tiseo M, Lin HM, Gupta N, Hanley MJ, Ni Q, Zhang P, Popat S. Camidge DR, et al. Among authors: lin hm. J Clin Oncol. 2020 Nov 1;38(31):3592-3603. doi: 10.1200/JCO.20.00505. Epub 2020 Aug 11. J Clin Oncol. 2020. PMID: 32780660 Free PMC article. Clinical Trial.

10

Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non-Small-Cell Lung Cancer.

Jahanzeb M, Lin HM, Pan X, Yin Y, Baumann P, Langer CJ. Jahanzeb M, et al. Among authors: lin hm. Clin Lung Cancer. 2021 Jan;22(1):49-57. doi: 10.1016/j.cllc.2020.08.003. Epub 2020 Sep 18. Clin Lung Cancer. 2021. PMID: 33250347 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

711 results

Search Page

Filters